ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 147 filers reported holding ANI PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 10.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,135,000 | -40.2% | 35,300 | -44.8% | 0.00% | -25.0% |
| Q2 2022 | $1,899,000 | +1.4% | 64,000 | -3.9% | 0.00% | +33.3% |
| Q1 2022 | $1,872,000 | -35.8% | 66,600 | +5.2% | 0.00% | -40.0% |
| Q4 2021 | $2,917,000 | +0.2% | 63,300 | -28.6% | 0.01% | 0.0% |
| Q3 2021 | $2,911,000 | -6.3% | 88,700 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $3,108,000 | -0.2% | 88,700 | +2.9% | 0.01% | 0.0% |
| Q1 2021 | $3,114,000 | +64.2% | 86,186 | +32.0% | 0.01% | +66.7% |
| Q4 2020 | $1,896,000 | +1.6% | 65,300 | -1.4% | 0.00% | -25.0% |
| Q3 2020 | $1,867,000 | -16.8% | 66,200 | -4.6% | 0.00% | -20.0% |
| Q2 2020 | $2,244,000 | -22.9% | 69,400 | -2.9% | 0.01% | -28.6% |
| Q1 2020 | $2,912,000 | -34.3% | 71,500 | -0.6% | 0.01% | 0.0% |
| Q4 2019 | $4,434,000 | -36.1% | 71,900 | -24.5% | 0.01% | -36.4% |
| Q3 2019 | $6,938,000 | -26.0% | 95,200 | -16.5% | 0.01% | -26.7% |
| Q2 2019 | $9,370,000 | +62.4% | 114,000 | +39.4% | 0.02% | +66.7% |
| Q1 2019 | $5,769,000 | +100.6% | 81,785 | +28.0% | 0.01% | +80.0% |
| Q4 2018 | $2,876,000 | -82.8% | 63,900 | -78.3% | 0.01% | -80.0% |
| Q3 2018 | $16,673,000 | -16.9% | 294,900 | -1.8% | 0.02% | -19.4% |
| Q2 2018 | $20,066,000 | +12.7% | 300,400 | -1.8% | 0.03% | +10.7% |
| Q1 2018 | $17,803,000 | +996.2% | 305,800 | +1113.5% | 0.03% | +833.3% |
| Q4 2017 | $1,624,000 | +27.4% | 25,200 | +3.7% | 0.00% | +50.0% |
| Q3 2017 | $1,275,000 | +12.1% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,137,000 | -5.5% | 24,300 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,203,000 | -24.2% | 24,300 | -7.3% | 0.00% | -33.3% |
| Q4 2016 | $1,588,000 | +50.7% | 26,200 | +64.8% | 0.00% | +50.0% |
| Q3 2016 | $1,054,000 | +18.8% | 15,900 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $887,000 | +62.8% | 15,900 | -1.9% | 0.00% | +100.0% |
| Q1 2016 | $545,000 | -28.1% | 16,200 | -3.6% | 0.00% | -50.0% |
| Q4 2015 | $758,000 | +88.1% | 16,800 | +64.7% | 0.00% | +100.0% |
| Q3 2015 | $403,000 | -36.2% | 10,200 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $632,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |